Chemed Corp (CHE)
NYSE · Healthcare · Medical Care Facilities
Chemed Corp is a Healthcare company with a market capitalization of $6.15B, a trailing P/E ratio of 25.3, and a dividend yield of 0.51%.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | April 23, 2026 | $5.65 | $5.30 | +6.6% |
| Q4 2025 | February 25, 2026 | $6.42 | $7.07 | -9.2% |
| Q3 2025 | October 28, 2025 | $5.27 | $5.37 | -1.9% |
| Q2 2025 | July 29, 2025 | $4.27 | $4.98 | -14.3% |
| Q1 2025 | April 23, 2025 | $5.63 | $5.55 | +1.4% |
| Q4 2024 | February 26, 2025 | $6.83 | $6.79 | +0.6% |
Other Medical Care Facilities Stocks
Frequently Asked Questions
What is Chemed Corp's market cap?
As of June 29, 2026, Chemed Corp (CHE) has a market capitalization of $6.15B.
What is Chemed Corp's P/E ratio?
Chemed Corp trades at a trailing price-to-earnings (P/E) ratio of 25.3. Its forward P/E is 18.7.
Does Chemed Corp pay a dividend?
Yes — Chemed Corp pays a dividend yielding 0.51%, an annual payout of $2.30 per share.
What sector is CHE in?
Chemed Corp is in the Healthcare sector, specifically the Medical Care Facilities industry.
What was Chemed Corp's revenue?
In its latest reported fiscal year (ending December 31, 2025), Chemed Corp reported revenue of $2.53B and net income of $265.24M.
Ask your own questions about CHE
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.